MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 358 filers reported holding MEDIVATION INC in Q4 2015. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,042,000 | +40.6% | 83,610 | +7.2% | 0.39% | +150.0% |
| Q1 2016 | $3,586,000 | -7.3% | 78,000 | -2.5% | 0.16% | -41.4% |
| Q4 2015 | $3,867,000 | +44.4% | 80,000 | +27.0% | 0.27% | +125.4% |
| Q3 2015 | $2,678,000 | +95.5% | 63,000 | +425.0% | 0.12% | +118.5% |
| Q2 2015 | $1,370,000 | -49.5% | 12,000 | -42.9% | 0.05% | -55.0% |
| Q1 2015 | $2,711,000 | +48.1% | 21,000 | -26.1% | 0.12% | +224.3% |
| Q1 2014 | $1,830,000 | -66.1% | 28,430 | -68.4% | 0.04% | -36.2% |
| Q3 2013 | $5,394,000 | +143.6% | 90,000 | +100.0% | 0.06% | -10.8% |
| Q2 2013 | $2,214,000 | – | 45,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
| Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
| BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
| PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
| Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
| Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
| Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
| Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
| Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |